Carregant...
Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia
OBJECTIVE: An immediate-release formulation of gabapentin is approved for treatment of postherpetic neuralgia (PHN). This formulation, however, requires multiple daily dosing, usually three times per day, and is associated with a high incidence of somnolence and dizziness. We assessed the tolerabili...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3392710/ https://ncbi.nlm.nih.gov/pubmed/22792006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S32562 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|